Thu, November 14, 2019
Wed, November 13, 2019
Tue, November 12, 2019
Mon, November 11, 2019
Fri, November 8, 2019
Thu, November 7, 2019
Wed, November 6, 2019
Tue, November 5, 2019

Alethia Young Maintained (SRPT) at Buy with Decreased Target to $185 on, Nov 8th, 2019


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. ith-decreased-target-to-185-on-nov-8th-2019.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Alethia Young of Credit Suisse, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Decreased Target from $201 to $185 on, Nov 8th, 2019.

Alethia has made no other calls on SRPT in the last 4 months.



There are 5 other peers that have a rating on SRPT. Out of the 5 peers that are also analyzing SRPT, 0 agree with Alethia's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Alethia


  • Whitney Ijem of "Guggenheim" Initiated at Strong Buy and Held Target at $183 on, Friday, November 1st, 2019
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $160 on, Friday, October 11th, 2019
  • Joel Beatty of "Citigroup" Maintained at Strong Buy with Decreased Target to $180 on, Friday, September 27th, 2019
  • Brian Skorney of "Baird" Maintained at Buy with Decreased Target to $181 on, Tuesday, August 20th, 2019
  • Yun Zhong of "Janney Montgomery Scott" Maintained at Strong Buy with Decreased Target to $175 on, Tuesday, August 20th, 2019

Publication Contributing Sources